99mTcO(BAT-NI), a novel nitroimidazole tracer: In vivo uptake studies in ischaemic myocardium

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 4, 2003, Pages 494-501

  Hoffend, J ^a   Linke, G ^a   Mohammed, A ^a   Tiefenbacher, C P ^a   Eisenhut, M ^b   Haberkorn, U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

BAT ligands; Ischaemia; Myocardium; Nitroimidazole; Technetium

Indexed keywords

2 NITROIMIDAZOLE DERIVATIVE; 2,10 DIMERCAPTO 2,10 DIMETHYL 4,8 DIAZA 6 (4 BROMOBUTYL)UNDECANE; 2,10 DIMERCAPTO 2,10 DIMETHYL 4,8 DIAZA 6 [4 (2 NITROIMIDAZOLYL)BUTYL]UNDECANE TECHNETIUM TC 99M; 2,10 DIMERCAPTO 2,10 DIMETHYL 4,8 DIAZA 6 [4 (IMIDAZOLYL)BUTYL]UNDECANE; BROMINE; IODINE 125; N [4 (4 IODOPHENOXY)BUTYL] 2 NITROIMIDAZOLE I 125; TECHNETIUM 99M; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; IMIDAZOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M, 2,10 DIMERCAPTO 2,10 DIMETHYL 4,8 DIAZA 6 (4 (2 NITROIMIDAZOLYL)BUTYL)UNDECANE; TECHNETIUM TC 99M, 2,10-DIMERCAPTO-2,10-DIMETHYL-4,8-DIAZA-6-(4-(2-NITROIMIDAZOLYL)BUTYL)UNDECANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BIOACCUMULATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IN VIVO STUDY; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRUCTURE ACTIVITY RELATION; THORACOTOMY; ANIMAL; ANTIBODY SPECIFICITY; COMPARATIVE STUDY; EVALUATION; FEASIBILITY STUDY; METABOLISM; SCINTISCANNING; TISSUE DISTRIBUTION; VALIDATION STUDY; WISTAR FURTH RAT;

ANIMALS; AUTORADIOGRAPHY; FEASIBILITY STUDIES; FEMALE; IMIDAZOLES; MYOCARDIAL ISCHEMIA; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, INBRED WF; TISSUE DISTRIBUTION;

EID: 0038331634     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-1093-x     Document Type: Article

References (21)

1. Martin GV, Caldwell JH, Graham MM, Grierson JR, Kroll K, Cowan MJ, Lewellen TK, Rasey JS, Casciari JJ, Krohn KA. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. J Nucl Med 1992; 33:2202-2208.
2. Caldwell JH, Revenaugh JR, Martin GV, Johnson PM, Rasey JS, Krohn KA. Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia. J Nucl Med 1995; 36:1633-1638.
3. Shi CQ, Sinusas AJ, Dione DP, Singer MJ, Young LH, Heller EN, Rinker BD, Wackers FJ, Zaret BL. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia. J Nucl Med 1995; 36:1078-1086.
4. Rumsey WL, Kuczynski B, Patel B, Bauer A, Narra RK, Eaton SM, Nunn AD, Strauss HW. SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand. J Nucl Med 1995; 36:1445-1450.
5. Stone CK, Mulnix T, Nickles RJ, Renstrom B, Nellis SH, Liedtke AJ, Nunn AD, Kuczynski BL, Rumsey WL. Myocardial kinetics of a putative hypoxic tissue marker, 99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion. Circulation 1995; 92:1246-1253.
6. Eisenhut M, Brandau W, Mißfeldt M. Synthesis of a bromobutyl substituted 1,2-dithia-5,9-diazacycloundecane: a versatile precursor for new99mTc bis(aminoethanethiol) complexes. J Nucl Med Biol 1989; 16:805-811.
7. Nicholl C, Mohammed A, Hull WE, Bubeck B, Eisenhut M. Pharmacokinetics of 123I-IMBA for melanoma imaging. J Nucl Med 1997; 38:127-133.
8. Tiefenbacher CP, Zimmermann R, Parekh N, Amann K, Tillmanns H, Rauch B, Kubler W. Preservation of myocardial blood flow by calcium antagonists does not prevent attenuation of regional myocardial function after repetitive brief periods of myocardial ischaemia in the rat heart. Eur Heart J 1995; 16:1057-1062.
9. Tiefenbacher CP, Ebert M, Niroomand F, Batkai S, Tillmanns H, Zimmermann R, Kubler W. Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart. Pflugers Arch 1997; 433:563-570.
10. Fukuchi K, Kusuoka H, Watanabe Y, Fujiwara T, Nishimura T. Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole. J Nucl Med 1996; 37:761-766.
11. Johnson LL, Schofield L, Donahay T, Mastrofrancesco P. Myocardial uptake of a99mTc-nitroheterocycle in a swine model of occlusion and reperfusion. J Nucl Med 2000; 41:1237-1243.
12. Di Rocco RJ, Bauer AA, Pirro JP, Kuczynski BL, Belnavis L, Chan YW, Linder KE, Narra RK, Nowotnik DP, Nunn AD. Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole. Nucl Med Biol 1997; 24:201-207.
13. Kusuoka H, Hashimoto K, Fukuchi K, Nishimura T. Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium. J Nucl Med 1994; 35:1371-1376.
14. Archer CM, Edwards B, Kelly JD, King AC, Burke JF, Riley ALM. Technetium labelled agents for imaging tissue hypoxia in vivo. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and rhenium in chemisty and nuclear medicine. Padova, Italy: SGE Ditoriali; 1995:535-539.
15. Sinusas AJ. The potential for myocardial imaging with hypoxia markers. Semin Nucl Med 1999; 29:330-338.
16. Linder KE, Chan YW, Cyr JE, Malley MF, Nowotnik DP, Nunn AD. TcO(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction. J Med Chem 1994; 37:9-17.
17. Oya S, Kung MP, Frederick D, Kung HF. New bisaminoethanethiol (BAT) ligands which form two interconvertible99mTc complexes. Nucl Med Biol 1995; 22:749-757.
18. Efange SM, Kung HF, Billings J, Guo YZ, Blau M. Technetium-99m bis (aminoethanethiol) complexes with amine sidechains - potential brain perfusion imaging agents for SPECT. J Nucl Med 1987; 28:1012-1019.
19. Bernard BF, Krenning EP, Breeman WA, Ensing G, Benjamins H, Bakker WH, Visser TJ, de Jong M.99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo. Nucl Med Biol 1998; 25:233-240.
20. Bouquillon S, Coulais Y, Dartiguenave M, Tafani JA, Guiraud R. Synthesis, characterization and biodistribution of a new technetium-99m complex with trimethylsilylmethylisonitrile. Comparison with99mTc-TBI and 99mTc-MIBI. Nucl Med Biol 1995; 22:585-588.
21. Okada RD, Johnson G 3rd, Nguyen KN, Liu Z, Edwards B, Archer CM, North TL, King AC, Kelly JD. 99mTc-HL91: "hot spot" detection of ischemic myocardium in vivo by gamma camera imaging. Circulation 1998; 97:2557-2566.